Trial Profile
Study to Evaluate the Safety and Efficacy of Extended Release Tacrolimus [Advagraf] + Sirolimus [Rapamune], Versus Extended Release Tacrolimus [Advagraf] + Mycophenolate Mofetil in Kidney Transplant Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Aug 2017
Price :
$35
*
At a glance
- Drugs Mycophenolate mofetil (Primary) ; Sirolimus (Primary) ; Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 01 Aug 2017 Results published in the Nephrology Dialysis Transplantation
- 03 May 2017 Results assessing efficacy and safety, presented at the 2017 American Transplant Congress
- 07 Mar 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.